Global Biotechnology Market

Global Biotechnology Market by Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), by Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2017

The biotechnology market is primarily driven by the regulatory support provided by governments of various countries, increasing food demand, advancement of technology to combat fatal diseases and depleting natural resources. However, certain factors like long lead time from research to commercialization, and the perception of consumers towards biotech products is restricting the growth of the biotechnology industry. Stem cell technology, cloning and nanotechnology are some of the rapidly emerging technologies in the biotechnology market today. 
 
The long lab-to-market phase of biopharmaceutical drugs is a major inhibitor for the market. It takes anywhere between 12 to 15 years for a drug to be commercially sold. In addition, social and ethical issues with clinical trials also act as a restraint for the development of the biotechnology market. 
 
North America is the largest market for biotechnology due to the higher adoption of biopharmaceuticals and increased preference towards bioservices due to higher cost in the region.
 
Biotechnology finds application in segments such as pharmaceuticals, downstream chemical processing, agriculture and bioservices among others. The biopharmaceutical segment mainly comprises of vaccines, insulin, monoclonal antibodies, generic and branded drugs. Biopharmacy is the largest segment of the biotechnology market. The bioindustrial segment is rapidly gaining market share in the overall biotechnology space due to increasing demand of bioenzymes and biofuels in various applications. The bioagriculture domain primarily focuses on bioseeds, genetically modified (GM) crops and biopesticides. This market is booming as the demand for food production is rising due to increasing population. North America is the leading consumer of GM crops. 
 
The bioservices segment is the fastest growing market in the Asia Pacific region due to low cost of clinical trials. Bioservices primarily comprise of CROs (Contract Research Organizations) involved in clinical trials, contract manufacturing and drug development. This has been a growing segment, especially in the Asia Pacific region with economies such as India and China registering growth of over 20%.
    Table of Content
     
    Chapter 1 Preface
    1.1 Report Description
    1.2 Research Methodology
     
    Chapter 2 Executive Summary
     
    Chapter 3 Market Overview
    3.1 Introduction
    3.2 Value Chain Analysis
    3.3 Market Drivers
          3.3.1 Regulatory Support
          3.3.2 Increasing Food Demand 
          3.3.3 Limited Availability of Non-Renewable Natural Resources
    3.4 Market Restraints
          3.4.1 Ethical Issues Associated with Clinical Trials
          3.4.2 Long Research and Development Lead Time
    3.5 Market Opportunities
          3.5.1 Emergence of Biosimilars
          3.5.2 Biotechnology in Medical Sciences
    3.6 Porters Five Force Analysis
          3.6.1 Bargaining Power of Suppliers
          3.6.2 Bargaining Power of Buyers
          3.6.3 Threat of New Entrants
          3.6.4 Threat from Substitutes
          3.6.5 Degree of Competition
    3.7 Biotechnology: Company Market Share Analysis
    3.8 Biotechnology: Market Attractiveness Analysis
          3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
          3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

    Chapter 4 Global Biotechnology Market, by Application
    4.1 Global Biotechnology Market: Application Overview
          4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
    4.2 Biotechnology Market, by Application, 2010 - 2017
          4.2.1 Biopharmacy
                  4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
          4.2.2 Bioservices
                  4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
          4.2.3 Bioagriculture
                  4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
          4.2.4 Bioindustrial
                  4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
     
    Chapter 5 Global Biotechnology Market, by Technology
    5.1 Global Biotechnology Market Overview, by Technology
          5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
    5.2 Fermentation Technology
          5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
    5.3 Tissue Engineering And Regeneration Technology
          5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017 (USD Billion)
    5.4 Polymerase Chain Reaction (PCR) Technology
          5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)
    5.5 Nanobiotechnology
          5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)
    5.6 Chromatography
          5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)
    5.7 Dna Sequencing Technology
          5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)
    5.8 Cell Based Assay
          5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
    5.9 Others (Enzyme Technology, Finger Printing, Etc.)
          5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)
     
    Chapter 6 Global Biotechnology Market, by Geography
    6.1 Global Biotechnology Market Overview, by Geography
          6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
    6.2 North America
          6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)
          6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017, (USD Billion)
                  6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)
                  6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)
                  6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)
                  6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USD Billion)
    6.3 Europe
          6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)
          6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
                  6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)
                  6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)
                  6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)
                  6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)
    6.4 Asia Pacific
          6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)
          6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
                   6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)
                   6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)
                   6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)
                   6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USD Billion)
    6.5 Rest Of World
          6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)
          6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 – 2017, (USD Billion)
                  6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)
                  6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)
                  6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)
                  6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)
     
    Chapter 7 Company Profile
    7.1 Abbott Laboratories
          7.1.1 Company Overview
          7.1.2 Financial Overview
          7.1.3 Business Strategies
          7.1.4 Swot Analysis
          7.1.5 Recent Developments
    7.2 Amgen Inc.
          7.2.1 Company Overview
          7.2.2 Financial Overview
          7.2.3 Business Strategy
          7.2.4 Swot Analysis
          7.2.5 Recent Developments
    7.3 Glaxosmithkline
          7.3.1 Company Overview
          7.3.2 Financial Overview
          7.3.3 Business Strategy
          7.3.4 Swot Analysis
          7.3.5 Recent Developments
    7.4 Johnson And Johnson
          7.4.1 Company Overview
          7.4.2 Financial Overview
          7.4.3 Business Strategy.
          7.4.4 Swot Analysis
          7.4.5 Recent Developments
    7.5 Merck
          7.5.1 Company Overview
          7.5.2 Financial Overview
          7.5.3 Business Strategy
          7.5.4 Swot Analysis
          7.5.5 Recent Developments
    7.6 Novartis
          7.6.1 Company Overview
          7.6.2 Financial Overview
          7.6.3 Business Strategy
          7.6.4 Swot Analysis
          7.6.5 Recent Developments
    7.7 Novo Nordisk
          7.7.1 Company Overview
          7.7.2 Financial Overview
          7.7.3 Swot Analysis
          7.7.4 Business Strategies
          7.7.5 Recent Developments
    7.8 Pfizer (Wyeth)
          7.8.1 Company Overview
          7.8.2 Financial Overview
          7.8.3 Business Strategies.
          7.8.4 Swot Analysis
          7.8.5 Recent Developments
    7.9 Roche
          7.9.1 Company Overview
          7.9.2 Financial Overview
          7.9.3 Business Strategies
          7.9.4 Swot Analysis
          7.9.5 Recent Developments
    7.10 Sanofi - Aventis
          7.10.1 Company Overview
          7.10.2 Financial Overview
          7.10.3 Business Strategy
          7.10.4 Swot Analysis
          7.10.5 Recent Developments
    7.11 Lonza Group Ltd.
          7.11.1 Company Overview
          7.11.2 Financial Overview
          7.11.3 Business Strategy
          7.11.4 Swot Analysis
          7.11.5 Recent Developments
    7.12 Biogen Idec Inc
          7.12.1 Company Overview
          7.12.2 Financial Overview
          7.12.3 Business Strategy
          7.12.4 Swot Analysis
          7.12.5 Recent Developments
    7.13 Astra Zeneca
          7.13.1 Company Overview
          7.13.2 Financial Overview
          7.13.3 Business Strategy
          7.13.4 Swot Analysis
          7.13.5 Recent Developments
    7.14 Genentech
          7.14.1 Company Overview
          7.14.2 Financial Overview
          7.14.3 Business Strategies
          7.14.4 Swot Analysis
          7.14.5 Recent Developments
    7.15 Genzyme
          7.15.1 Company Overview
          7.15.2 Financial Overview
          7.15.3 Swot Analysis
          7.15.4 Recent Developments
    7.16 Gilead Sciences
          7.16.1 Company Overview
          7.16.2 Financial Overview
          7.16.3 Swot Analysis
          7.16.4 Business Strategies
          7.16.5 Recent Developments
    7.17 Celgene
          7.17.1 Company Overview
          7.17.2 Financial Overview
          7.17.3 Business Strategy
          7.17.4 Swot Analysis
          7.17.5 Recent Developments
    List of Tables
     
    Table 1 Biotechnology Market: Global Snapshot
    Table 2 Drivers For Biotechnology Market: Impact Analysis
    Table 3 Restraints For Biotechnology Market : Impact Analysis

    List of Figures 

     

    Fig. 1 Global Biotechnology Market, 2010 – 2017, (USD Billion)

    Fig. 1 Biotechnology Industry: Value Chain Analysis

    Fig. 2 World Population Growth, Billion, 2006 - 2012

    Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011

    Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 – 2018 (USD/Barrel)

    Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018

    Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011

    Fig. 7 Stages Involved In Drug Approval

    Fig. 8 Porters Five Forces Analysis

    Fig. 9 Biotechnology : Company Market Share, 2011

    Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011

    Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011

    Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017

    Fig. 13 Global Biopharmacy Market, 2010 – 2017 (USD Billion)

    Fig. 14 Global Bioservices Market, 2011 – 2017 (USD Billion)

    Fig. 15 Global Bioagriculture Market, 2010 – 2017 (USD Billion)

    Fig. 16 Global Bioindustrial Market, 2011 – 2017 (USD Billion)

    Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017

    Fig. 18 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)

    Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 – 2017 (USD Billion)

    Fig. 20 Global PCR Technology Market, 2010 – 2017 (USD Billion)

    Fig. 21 Global Nanobiotechnology Market, 2010 – 2017 (USD Billion)

    Fig. 22 Global Chromatography Market, 2010 – 2017 (USD Billion)

    Fig. 23 Global Dna Sequencing Technology Market, 2010 – 2017 (USD Billion)

    Fig. 24 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)

    Fig. 25 Global Other Technologies Market, 2010 – 2017 (USD Billion)

    Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017

    Fig. 27 North America Market For Biotechnology, 2010 – 2017, (USD Billion)

    Fig. 28 Demand For Biopharmacy In North America, 2010 – 2017, (USD Billion)

    Fig. 29 Demand For Bioservices In North America, 2010 – 2017, (USD Billion)

    Fig. 30 Demand For Bioagriculture In North America, 2010 – 2017, (USD Billion)

    Fig. 31 Demand For Bioindustrial Products In North America, 2010 – 2017, (USD Billion)

    Fig. 32 Europe Market For Biotechnology, 2010 – 2017, (USD Billion)

    Fig. 33 Demand For Biopharmacy In Europe, 2010 – 2017, (USD Billion)

    Fig. 34 Demand For Bioservices In Europe, 2010 – 2017, (USD Billion)

    Fig. 35 Demand For Bioagriculture In Europe, 2010 – 2017, (USD Billion)

    Fig. 36 Demand For Bioindustrial Products In Europe, 2010 – 2017, (USD Billion)

    Fig. 37 Asia Pacific Market For Biotechnology, 2010 – 2017, (USD Billion)

    Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 – 2017, (USD Billion)

    Fig. 39 Demand For Bioservices In Asia Pacific, 2010 – 2017, (USD Billion)

    Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 – 2017, (USD Billion)

    Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 – 2017, (USD Billion)

    Fig. 42 Rest Of World Market For Biotechnology, 2010 – 2017, (USD Billion)

    Fig. 43 Demand For Biopharmacy In Row, 2010 – 2017, (USD Billion)

    Fig. 44 Demand For Bioservices In Row, 2010 – 2017, (USD Billion)

    Fig. 45 Demand For Bioagriculture In Row, 2010 – 2017, (USD Billion)

    Fig. 46 Demand For Bioindustrial Products In Row, 2010 – 2017, (USD Billion)

Copyright © Transparency Market Research, Inc. All Rights reserved